← SynDRA
ARBUTAMINE
SynDRA canonical compound SYN0023497 — structure-anchored drug synonym record
| Clinical phase | Withdrawn |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | ADRB1 | ADRB2 | ADRB3 |
|---|
| Mechanism of action | adrenergic receptor agonist |
|---|
| Indication | coronary artery disease (cad) |
|---|
| Disease area | cardiology |
|---|
All known targets
Mechanisms of action (all sources)
- adrenergic receptor agonist
- ADRB1 STIMULATOR
- ADRB1 AGONIST
Drug classes
- Adrenergic Agents
- Adrenergic Agonists
- Adrenergic beta-Agonists
- Cardiotonic Agents
- Cardiovascular Agents
- Neurotransmitter Agents
- Protective Agents
ATC classes
- C01C · CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Cross-references
Synonyms
- genesa
- arbutamine hydrochloride
- arbutamine HCl
- Arbutamina
- Arbutaminum
- Genesa
- Arbutamina [INN-Spanish]
- Arbutamine [INN:BAN]
- Arbutaminum [INN-Latin]
- 4-[(1R)-1-hydroxy-2-[4-(4-hydroxyphenyl)butylamino]ethyl]benzene-1,2-diol
- 4-[(1R)-1-hydroxy-2-{[4-(4-hydroxyphenyl)butyl]amino}ethyl]benzene-1,2-diol
- 4-[1-hydroxy-2-[4-(4-hydroxyphenyl)butylamino]ethyl]benzene-1,2-diol
- B07L15YAEV
- CHEBI:50580
- (-)-Arbutamine
- RefChem:559910
- DTXCID3078399
- C01CA22
- UNII-B07L15YAEV
- ARBUTAMINE [MI]
- ARBUTAMINE [INN]
- ARBUTAMINE [VANDF]
- ARBUTAMINE [WHO-DD]
- SCHEMBL521645
- orb1710395
- SCHEMBL29390265
- EBC-26772
- MFCD16628073
- AKOS040732463
- HY-16056
- MS-24685
- DB-228967
- CS-0006131
- NS00002336
- G13889
- T10364
- EN300-18815718
- آربوتامین
Look up ARBUTAMINE in the interactive SynDRA portal →